DrugMar 8, 2023
Accord Healthcare Phenylephrine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL) recall — FDA D-0402-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
Recall history in this database
Classification mix: Class II: 86, Class III: 2, Class I: 2.
DrugMar 8, 2023
Accord Healthcare Clopidogrel Tablets USP, 75 mg recall — FDA D-0380-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Tadalafil Tablets, USP, 5 mg recall — FDA D-0415-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Glimepiride Tablets USP, 4 mg recall — FDA D-0395-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Glycopyrrolate Injection, USP, 0.2 mg/mL, 1 mL Single Dose Vial x 25 vials recall — FDA D-0396-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Aripiprazole Tablets, USP 30 mg recall — FDA D-0370-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
rOPINIRole Tablets USP 4 mg* 100-count bottle recall — FDA D-0430-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Finasteride Tablets USP, 5 mg recall — FDA D-0392-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Aripiprazole Tablets, USP 5 mg recall — FDA D-0366-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Doxazosin Tablets USP, 4 mg recall — FDA D-0388-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
rOPINIRole Tablets USP 0.5 mg*, 100-count bottle recall — FDA D-0426-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Finasteride Tablets USP, 1 mg recall — FDA D-0390-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Pravastatin Sodium Tablets USP, 10 mg recall — FDA D-0421-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Pravastatin Sodium Tablets USP 20 mg recall — FDA D-0422-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugFeb 1, 2023
Allopurinol Tablets USP, 100 mg, 100-count bottle recall — FDA D-0168-2023
Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugJan 25, 2023
Accord Healthcare Daptomycin for Injection 350 mg/vial 1 Single-dose vial recall — FDA D-0131-2023
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
Class IFDA: TerminatedAccord Healthcare, Inc.
DrugFeb 17, 2021
Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials recall — FDA D-0250-2021
Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials
Class IIIFDA: TerminatedAccord Healthcare, Inc.
DrugSep 19, 2018
Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle recall — FDA D-1206-2018
Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.
Class IFDA: TerminatedAccord Healthcare, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Accord Healthcare, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.